Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months

After receiving the patent for a particular molecule, according to a senior official. Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. “We … Read more

Deloitte has designed programme that can be scaled in Covid fight, says CEO

Deloitte, one of the Big Four accounting organisations, has developed “a very innovative, simple, fit-for-purpose programme” in the fight against COVID-19 that can be scaled up in a quick span of time, its CEO Punit Renjen said on Monday. “We have designed, I believe, a very innovative, simple, fit-for-purpose programme that is integrated,” Renjen told … Read more

Over 300 pharma, healthcare companies eligible for new Covid loans

As many as 354 Crisil-rated companies, predominantly pharmaceutical firms and hospitals, with an aggregate bank exposure of Rs 40,000 crore will be eligible for Covid loans from lenders under RBI’s liquidity facility.   Though pharmaceutical firms account for 68 per cent of rated bank exposure, hospitals (about 24 per cent of rated exposure) are likely … Read more

Baillie Gifford scored a gain of $27.6 billion by betting early on Moderna, Tesla and Alibaba. Its team breaks down the 3-part strategy it uses to discover transformational stocks that offer…

Edinburgh-based firm Baillie Gifford took early bets in some of last year’s biggest winners. Tesla, Moderna and Alibaba have made the firm profits of around $27.6 billion – Bloomberg data. The Baillie Gifford team told Insider their 3 tips to making a success of active investing. Visit the Business section of Insider for more stories. … Read more

Blackstone, Partners Group Holding in race to acquire Piramal Glass

The investment firms have progressed to the final round of bidding for India’s Piramal Glass, the people said, asking not to be identified as the information is private. Billionaire Ajay Piramal’s conglomerate is seeking a valuation of $1 billion for the unit from the sale, the people said. Piramal could name a winner as soon … Read more

Capital International buys bulk of Analjit Singh’s stake in Max Healthcare

London-based wealth management giant Capital International Group on Friday bought 4.6% stake from Max group’s founder Analjit Singh in Max Healthcare for around ₹515 crore. Two persons aware of the development confirmed this, adding that proceeds from the stake sale by Singh will primarily be used for paying off the debts that Singh owes in … Read more